GNRX
VanEck Vectors Generic Drugs ETF
stock NASDAQ

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Indxx Global Generics & New Pharma Index. The index includes exchange-listed companies, on a global basis, that derive a significant proportion of their revenues (or that have the potential to derive a significant proportion of their revenues) from the generic drug industry, or that have a primary business focus on the generic drug industry. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. It is non-diversified.